Economic impact of a rational use of antibiotics in intensive care

Intensive Care Medicine

Volumn 25, Issue 12, 1999, Pages 1407-1412

  Blanc, P ^a,c   Von Elm, B E ^b   Geissler, A ^a   Granier, I ^a   Boussuges, A ^a   Durand Gasselin, J ^a  

^a Hopital Font Pre   (France)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Centre Hospitalier Departemental Felix Guyon   (France)

Author keywords

Antibiotics; Cost control; Drug costs; Financial management; Intensive care; Quality of health care

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; DRUG COST; DRUG USE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG COSTS; DRUG UTILIZATION REVIEW; FEMALE; FRANCE; HOSPITAL COSTS; HOSPITALS, GENERAL; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 0033371879     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340051089     Document Type: Article

References (24)

1. De Pouvourville G (1995) Pourquoi maîtriser les dépenses de santé? In: Société de Réanimation de Langue Française (ed) Actualités en réanimation et urgences. Arnette, Paris, pp 3-11
2. Blanc P, Gainnier M, Granier I, Guigues V, Boussuges A, Geissler A, Durand-Gasselin J (1997) Economic impact of a prescribing protocol in an intensive care unit. Ann Fr Anesth Reanim 16: 873-878
3. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270: 2957-2963
4. Sznajder M, Leleu G, Buonamico G, Auvert B, Aegerter P, Merliere Y, Dutheil M, Guidet B, Le Gall JR (1998) Estimation of direct cost and resource allocation in intensive care: correlation with Omega system. Intensive Care Med 24: 582-589
5. Jacobs P, Noseworthy TW (1990) National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 18: 1282-1286
6. Luce JM (1991) Improving the quality and utilization of critical care. Qual Rev Bull 17: 42-47
7. Stoddart GL, Barer ML (1992) Towards integrated medical resource policies for Canada: improving effectiveness and efficiency. Can Med Assoc J 147: 1653-1660
8. Jones DL, Kroenke K, Landry FJ, Tomich DJ, Ferrel RJ (1996) Cost saving using a stepped-care prescribing protocol for non steroidal anti-inflammatory drugs. JAMA 275: 926-930
9. McFadden ER Jr, Elsanadi N, Dixon L, Takacs M, Deal EC, Boyd KK, Idemoto BK, Broseman LA, Panuska J, Hammons T et al (1995) Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med 99: 651-661
10. Granier I, Merlin D, Delorme J, Facon K, Garcia E, Blanc P, Geissler A, Durand-Gasselin J (1998) Managing health care economics: advantage of a quality improvement program [abstract]. Intensive Care Med 23 (Suppl 1):S 155
11. Kunin CM (1981) Evaluation of antibiotic usage. A comprehensive look at alternative approaches. Rev Infect Dis 3: 745-753
12. McGowan JE Jr (1983) Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5: 1033-1048
13. Grayson ML, Eliopoulos GM (1991) Antimicrobial resistance in intensive care unit. Semin Respir Infect 5: 204-214
14. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 275: 234-240
15. Moro ML, Jepsen OB, The Euronis Study Group (1996) Euronis infection control practices in intensive care units of 14 European countries. Intensive Care Med 22: 872-879
16. McGowan JE Jr (1986) Minimizing antimicrobial resistance in hospital bacteria: can switching or cycling drugs help? Infect Control 7: 573-576
17. Klem C, Dasta JF (1996) Efforts of pharmacy to reduce antibiotic resistance. New Horiz 4: 377-384
18. Von Rosensteil N, Adam D (1994) Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs 47: 872-901
19. Beaucaire G (1997) Management of aminoglycosides used in association. Rean Urg 6: 23 s-29 s
20. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A et al (1991) The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100: 1619-1636
21. Kerridge R, Glasziou P, Hillman K (1995) The use of "quality-adjusted life-years" (QALYS) to evaluate treatment in intensive care. Anaesth Intensive Care 23: 322-331
22. Relman AS (1990) Is rationing inevitable? N Engl J Med 332: 1809-1810
23. Driedger AA (1996) Developing a quality improvement program. In: Sibbald WJ, Massaro TA (eds) The business of critical care. Futura, New York, pp 149-165
24. Agence nationale pour le developpement de l'évaluation médicale (1998) Texte des recommandations. In: Le bon usage des antibiotiques à l'hôpital. Paris